Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Simon Pernot

9PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Jul 13, 2026
A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus.

|Jun 14, 2025
Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study.

Camille Evrard, Antoine Pelras, Simon Rivet

|Dec 15, 2023
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.

Clémence Flecchia, Edouard Auclin, Emily Alouani

|Feb 12, 2022
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study.

Sonia Zaibet, Vincent Hautefeuille, Edouard Auclin

|Jan 30, 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study.

Sonia Zaibet, Vincent Hautefeuille, Edouard Auclin

|Jun 09, 2020
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.

Simon Pernot, Olivier Pellerin, Pascal Artru

Pageof 2

Frequent Collaborators

4 joint publications

Julien Taieb

3 joint publications

David Tougeron

2 joint publications

Christelle De La Fouchardière

2 joint publications

Julien Edeline

1 joint publications

Antoine Hollebecque

1 joint publications

Vincent Hautefeuille

1 joint publications

Thomas Aparicio

1 joint publications

Camille Evrard

1 joint publications

Jean-Baptiste Bachet

1 joint publications

Laëtitia Dahan

Frequent Collaborators

4 joint publications

Julien Taieb

3 joint publications

David Tougeron

2 joint publications

Christelle De La Fouchardière

2 joint publications

Julien Edeline